An enzyme inhibitor that regulates insect larvae development reduces heart enlargement and irregular heart rhythms in a mouse model, a 16-member University of California, Davis research team has discovered. The work, published in the current edition of Proceedings of the National Academy of Sciences, could lead to important new medications to treat human heart patients.
The news that the world’s first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer “highlights a truly significant advance in the management of breast cancer,” says Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Fla.
Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine (NEJM).
A check of US metro-area hospitals showed that most already are using newly recommended best practices for treating heart attack patients, unblocking arteries within 90 minutes of patients arriving at emergency rooms.
A device first implanted in the United States at the University of Rochester Medical Center as part of a clinical trial is showing a significant reduction in blood pressure in patients who suffer from severe hypertension and cannot control their condition with medications or lifestyle changes.
In the largest review of “broken heart syndrome” patients ever conducted, Mayo Clinic researchers studied 100 patients and found symptoms recurred in 1 out of 10 patients over a four-year period, and that patients experiencing physical stress had a worse survival rate than those under emotional stress.
Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine.
A new combination of a potent anticoagulant and an antidote that stops its action, has proved to be safe in its first clinical trial in humans, according to the team conducting the trial.
A simple points system may soon help guide treatment of elderly heart failure patients. Researchers at Washington University School of Medicine in St. Louis found that by counting how many of seven easy-to-obtain health factors a patient has, physicians can estimate the patient’s risk of dying.
Difficulties in the heart’s ability to fill with blood are common causes of heart failure — and appear to be as significant in placing a heart patient at risk of death as are deficiencies in the heart’s ability to pump blood, new research from Mayo Clinic shows.